跳至主要内容
临床试验/NCT00763711
NCT00763711终止1 期

Injectable Bulking Agent Needle Guide

Carbon Medical Technologies4 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2008年6月1日最近更新:
适应症

试验速览

阶段
1 期
状态
终止
发起方
入组人数
17
试验地点
4
主要终点
to evaluate the consistency of the location of the injection site and resulting location of bulking effect

研究概览

简要总结

The purpose of this study is to evaluate the use of the Needle Guide as an assist in properly guiding an injection needle into the appropriate tissue plane during an injectable bulking agent procedure in women using a FDA approved injectable bulking agent. The injectable bulking agent will be Durasphere EXP.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Individuals satisfying the "Indications" and "Contraindications" criteria in the Durasphere EXP Directions for Use may participate.

排除标准

  • 未提供

结局指标

主要结局

to evaluate the consistency of the location of the injection site and resulting location of bulking effect

时间窗: at procedure

Safety will be demonstrated through an analysis of morbidity and complication rates, (if any), associated with the use of the Needle Guide.

时间窗: 1 week

次要结局

  • to evaluate the comparative ease of the injection procedure using the Bulking Agent Needle Guide as compared to the traditional transurethral or periurethral injection technique.(at procedure)

研究者

发起方
Carbon Medical Technologies
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验